Caryn Kesselmeyer
About Caryn Kesselmeyer
Caryn Kesselmeyer is the Operations Lead for Global Capital Project Engineering at Bristol Myers Squibb, with over a decade of experience in the pharmaceutical industry, including roles in both clinical operations and project engineering.
Company
Caryn Kesselmeyer is currently working at Bristol Myers Squibb. The organization is a globally recognized pharmaceutical company focused on biopharmaceutical research and development.
Title
Caryn Kesselmeyer holds the position of Operations Lead in Global Capital Project Engineering. Her role involves overseeing the operational aspects of large-scale capital projects on a global level.
Education and Expertise
Caryn Kesselmeyer studied Public Administration at Kean University, where she achieved a Bachelor of Arts (BA) degree. Her expertise spans clinical operations and project engineering, backed by over a decade of experience in the pharmaceutical industry.
Career Background
Caryn Kesselmeyer has a robust career background, initially starting as a Customer Service Associate at Celgene from 2013 to 2014. She transitioned into roles such as Clinical Trial Coordinator and Associate in Clinical Operations from 2014 to 2017, before moving into project engineering roles. She served as Sr. Project Coordinator and Lead Project Specialist in Global Project Engineering & GMP Facilities at Celgene. She played significant roles during Celgene’s acquisition by Bristol Myers Squibb, securing a smooth transition.
Achievements in Project Management
Caryn Kesselmeyer has a proven track record in managing GMP (Good Manufacturing Practice) facilities and leading high-stakes projects globally. Her project management skills are demonstrated through successful coordination and leadership on multiple key projects, ensuring regulatory compliance and operational efficiency.